Time Saver Recombinant Mouse Akt3 Protein (aa 106-479)(active) Full Package [tCRwEhbk]

Recombinant Mouse AKT3 Protein (Active): Your Reliable Research Tool

The Time Saver Recombinant Mouse Akt3 Protein (aa 106-479)(active) Full Package [tCRwEhbk] is a high-quality research tool designed for researchers in the fields of oncology, neuroscience, and cellular biology. This protein is expressed in Baculovirus-Insect Cells, ensuring optimal activity and purity. With a calculated molecular weight of 43.4 kDa and observed molecular weight of 46 kDa, this Active AKT3 protein is ideal for various in vitro assays and experiments.

• Expressed in Baculovirus-Insect Cells for high activity
• Sequence Ala106-Glu479, ensuring accurate representation
• Bio-activity confirmed with synthetic GSK3-derived peptide

Key Product Properties and Specifications

The Time Saver Recombinant Mouse Akt3 Protein (aa 106-479)(active) Full Package [tCRwEhbk] is meticulously produced to meet the highest standards of quality control. It is >95% pure as determined by reducing SDS-PAGE and contains <1.0 EU per μg of the protein, as assessed by the LAL method. The protein is supplied as a sterile solution in 20mM Tris, 500mM NaCl, 10% glycerol, pH 7.4, making it easy to use and handle.

• Purity >95% as determined by SDS-PAGE
• Endotoxin <1.0 EU per μg of the protein
• Storage Stable for 6 months at < -20°C

Applications and Benefits in Research

The Time Saver Recombinant Mouse Akt3 Protein (aa 106-479)(active) Full Package [tCRwEhbk] is a valuable tool for studying the role of AKT3 in various diseases, such as melanoma and gliomas. Its high purity, activity, and specific properties make it suitable for use in a wide range of applications, including cell signaling studies, drug discovery, and therapeutic research. By using this protein, researchers can gain a better understanding of the complex processes involved in tumor development and progression, potentially leading to new treatment strategies.

• Studying AKT3 signaling in oncology and neuroscience
• Applying in drug discovery and therapeutic research
• Targeting melanoma and gliomas for potential therapeutic intervention